| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 1.05e-06 | 9 | 194 | 4 | GO:0010854 | |
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 8.90e-06 | 5 | 194 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 1.77e-05 | 6 | 194 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 2.38e-05 | 18 | 194 | 4 | GO:0010851 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 4.50e-05 | 97 | 194 | 7 | GO:0008081 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 5.86e-05 | 43 | 194 | 5 | GO:0043548 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 6.09e-05 | 70 | 194 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 9.31e-05 | 25 | 194 | 4 | GO:0031683 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 1.03e-04 | 10 | 194 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA3 ABCF1 ATAD5 CFTR RSF1 CHD3 CHD4 LONP1 DNAH5 DYNC1H1 KIF13B DNAH3 KIF23 ABCE1 | 1.10e-04 | 441 | 194 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.56e-04 | 118 | 194 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 1.90e-04 | 162 | 194 | 8 | GO:0099106 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 2.40e-04 | 13 | 194 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 3.04e-04 | 14 | 194 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | titin binding | 3.04e-04 | 14 | 194 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | channel regulator activity | 3.08e-04 | 174 | 194 | 8 | GO:0016247 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA3 ABCF1 MYL6 ATAD5 CFTR RSF1 CHD3 CHD4 LONP1 DNAH5 DYNC1H1 KIF13B DNAH3 KIF23 ABCE1 DNAI2 | 3.42e-04 | 614 | 194 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | transporter regulator activity | 3.46e-04 | 177 | 194 | 8 | GO:0141108 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 4.61e-04 | 16 | 194 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 4.61e-04 | 16 | 194 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 5.55e-04 | 17 | 194 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 5.56e-04 | 4 | 194 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | allyl-alcohol dehydrogenase activity | 5.56e-04 | 4 | 194 | 2 | GO:0047655 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA3 ABCF1 GBP7 ATAD5 CFTR RSF1 CHD3 CHD4 LONP1 DNAH5 DYNC1H1 KIF13B DNAH3 KIF23 TPPP RGS12 ARHGAP5 ABCE1 | 5.77e-04 | 775 | 194 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 6.62e-04 | 18 | 194 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 9.11e-04 | 20 | 194 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | dinitrosyl-iron complex binding | 9.21e-04 | 5 | 194 | 2 | GO:0035731 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | PDE4B MYL4 CETN1 CETN2 SPTA1 ADGRV1 CEP350 PTPRN FKBP4 KIF13B FLNC KIF23 ANK2 CALM1 CALM2 CALM3 CEP290 TPPP FSD1 SPAG9 COTL1 OPHN1 | 1.05e-03 | 1099 | 194 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | retinal binding | 1.06e-03 | 21 | 194 | 3 | GO:0016918 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 1.21e-03 | 22 | 194 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.37e-03 | 6 | 194 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA3 ABCF1 GBP7 ATAD5 CFTR RSF1 CHD3 CHD4 LONP1 DNAH5 DYNC1H1 KIF13B DNAH3 KIF23 TPPP RGS12 ARHGAP5 ABCE1 | 1.42e-03 | 839 | 194 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | PDE4B PDE4D INPP5D CHRM5 PTPRN PTPRN2 PTPRQ PLCB2 FAM83B FICD PLCE1 | 1.44e-03 | 386 | 194 | 11 | GO:0042578 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA3 ABCF1 GBP7 ATAD5 CFTR RSF1 CHD3 CHD4 LONP1 DNAH5 DYNC1H1 KIF13B DNAH3 KIF23 TPPP RGS12 ARHGAP5 ABCE1 | 1.44e-03 | 840 | 194 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA3 ABCF1 GBP7 ATAD5 CFTR RSF1 CHD3 CHD4 LONP1 DNAH5 DYNC1H1 KIF13B DNAH3 KIF23 TPPP RGS12 ARHGAP5 ABCE1 | 1.44e-03 | 840 | 194 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 1.87e-03 | 54 | 194 | 4 | GO:0005246 | |
| GeneOntologyMolecularFunction | steroid delta-isomerase activity | 1.91e-03 | 7 | 194 | 2 | GO:0004769 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 1.99e-03 | 26 | 194 | 3 | GO:0004435 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 2.22e-03 | 27 | 194 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.47e-03 | 28 | 194 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | calcium ion binding | MYL4 MYL6 CETN1 CETN2 SPTA1 ADGRV1 F7 F10 LPCAT2 EHD1 PLCB2 CALM1 CALM2 CALM3 DSG4 PROC | 2.72e-03 | 749 | 194 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | glutathione transferase activity | 2.74e-03 | 29 | 194 | 3 | GO:0004364 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 2.74e-03 | 29 | 194 | 3 | GO:0004629 | |
| GeneOntologyMolecularFunction | isomerase activity | 2.77e-03 | 192 | 194 | 7 | GO:0016853 | |
| GeneOntologyMolecularFunction | NADP binding | 3.11e-03 | 62 | 194 | 4 | GO:0050661 | |
| GeneOntologyMolecularFunction | heterotrimeric G-protein binding | 3.23e-03 | 9 | 194 | 2 | GO:0032795 | |
| GeneOntologyMolecularFunction | NADP+ binding | 3.23e-03 | 9 | 194 | 2 | GO:0070401 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 3.64e-03 | 32 | 194 | 3 | GO:0004033 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 8.32e-07 | 3 | 195 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 3.61e-06 | 12 | 195 | 4 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 3.61e-06 | 12 | 195 | 4 | GO:1901844 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 8.21e-06 | 5 | 195 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.37e-05 | 33 | 195 | 5 | GO:0010880 | |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 1.63e-05 | 6 | 195 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 1.63e-05 | 6 | 195 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 2.14e-05 | 18 | 195 | 4 | GO:0010649 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 2.45e-05 | 37 | 195 | 5 | GO:0014808 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 3.18e-05 | 39 | 195 | 5 | GO:1903514 | |
| GeneOntologyBiologicalProcess | regulation of cytokinesis | 4.33e-05 | 99 | 195 | 7 | GO:0032465 | |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 4.50e-05 | 8 | 195 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 4.62e-05 | 100 | 195 | 7 | GO:0061337 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 4.96e-05 | 22 | 195 | 4 | GO:0010881 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 5.78e-05 | 44 | 195 | 5 | GO:0070296 | |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 6.70e-05 | 9 | 195 | 3 | GO:0060316 | |
| GeneOntologyBiologicalProcess | negative regulation of relaxation of cardiac muscle | 8.89e-05 | 2 | 195 | 2 | GO:1901898 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 8.98e-05 | 111 | 195 | 7 | GO:0006942 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 9.84e-05 | 26 | 195 | 4 | GO:0086064 | |
| GeneOntologyBiologicalProcess | muscle contraction | DOCK4 PDE4B PDE4D MYL4 MYL6 KLHL41 AGT ANK2 CALM1 CALM2 CALM3 CERT1 SLC8A3 | 1.18e-04 | 400 | 195 | 13 | GO:0006936 |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 1.30e-04 | 11 | 195 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 1.33e-04 | 28 | 195 | 4 | GO:0010882 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CETN1 CETN2 CHD3 CNTLN CEP350 FSIP2 DNAH5 FKBP4 DYNC1H1 KIF23 CEP290 TPPP FSD1 DNAI2 SENP6 PAX6 HYDIN CFAP46 | 1.73e-04 | 720 | 195 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | CETN1 CETN2 CHD3 CNTLN CEP350 FSIP2 VPS13A DNAH5 FKBP4 DYNC1H1 KIF13B DNAH3 KIF23 IFT57 CEP290 TPPP FSD1 NSUN7 DNAI2 SENP6 PAX6 HYDIN CFAP46 | 1.74e-04 | 1058 | 195 | 23 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 1.75e-04 | 30 | 195 | 4 | GO:0098901 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 2.00e-04 | 89 | 195 | 6 | GO:0055117 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 2.22e-04 | 13 | 195 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.30e-04 | 217 | 195 | 9 | GO:0006941 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 2.37e-04 | 59 | 195 | 5 | GO:0086065 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 3.22e-04 | 35 | 195 | 4 | GO:0010644 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 4.26e-04 | 16 | 195 | 3 | GO:1901841 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 4.86e-04 | 146 | 195 | 7 | GO:0051209 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 4.92e-04 | 39 | 195 | 4 | GO:1901021 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 5.06e-04 | 147 | 195 | 7 | GO:0051283 | |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 5.13e-04 | 17 | 195 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 5.49e-04 | 149 | 195 | 7 | GO:0051282 | |
| GeneOntologyCellularComponent | centrosome | TGIF2 PDE4B AHI1 PDE4D CETN1 CETN2 CHD3 CHD4 CNTLN SFR1 CEP350 DYNC1H1 KIF23 CALM1 CALM2 CALM3 IFT57 CEP290 FSD1 SPAG9 CCDC141 KIAA1217 CYTH4 | 9.06e-07 | 770 | 195 | 23 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | TGIF2 PDE4B AHI1 PDE4D CETN1 CETN2 CHD3 CHD4 CNTLN SFR1 CEP350 DYNC1H1 KIF23 CALM1 CALM2 CALM3 IFT57 CEP290 TPPP FSD1 SPAG9 CCDC141 KIAA1217 CYTH4 | 5.31e-06 | 919 | 195 | 24 | GO:0005815 |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 5.40e-06 | 48 | 195 | 6 | GO:0032391 | |
| GeneOntologyCellularComponent | ciliary transition zone | 1.07e-05 | 81 | 195 | 7 | GO:0035869 | |
| GeneOntologyCellularComponent | myofibril | 2.55e-04 | 273 | 195 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | sperm midpiece | 3.27e-04 | 64 | 195 | 5 | GO:0097225 | |
| GeneOntologyCellularComponent | calyx of Held | 3.42e-04 | 36 | 195 | 4 | GO:0044305 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 4.12e-04 | 290 | 195 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 4.12e-04 | 238 | 195 | 9 | GO:0097729 | |
| GeneOntologyCellularComponent | sarcomere | 5.71e-04 | 249 | 195 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | calcium channel complex | 6.03e-04 | 73 | 195 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | supramolecular fiber | PDE4B PDE4D MYL4 INPP5D KLHL41 DNAH5 FKBP4 DYNC1H1 KIF13B FLNC DNAH3 KIF23 ANK2 CALM1 CALM2 CALM3 TPPP FSD1 LMNB2 COTL1 SLC8A3 DNAI2 AHNAK2 | 6.61e-04 | 1179 | 195 | 23 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | PDE4B PDE4D MYL4 INPP5D KLHL41 DNAH5 FKBP4 DYNC1H1 KIF13B FLNC DNAH3 KIF23 ANK2 CALM1 CALM2 CALM3 TPPP FSD1 LMNB2 COTL1 SLC8A3 DNAI2 AHNAK2 | 7.25e-04 | 1187 | 195 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | axon terminus | 8.20e-04 | 210 | 195 | 8 | GO:0043679 | |
| GeneOntologyCellularComponent | costamere | 1.08e-03 | 22 | 195 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | microtubule | DNAH5 FKBP4 DYNC1H1 KIF13B DNAH3 KIF23 CALM1 CALM2 CALM3 TPPP FSD1 SLC8A3 DNAI2 | 1.55e-03 | 533 | 195 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.58e-03 | 25 | 195 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.59e-03 | 233 | 195 | 8 | GO:0044306 | |
| GeneOntologyCellularComponent | dynein complex | 1.61e-03 | 54 | 195 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | photoreceptor distal connecting cilium | 1.76e-03 | 7 | 195 | 2 | GO:0120206 | |
| GeneOntologyCellularComponent | cilium | AHI1 CETN1 CETN2 ADGRV1 FSIP2 EHD1 VPS13A CPLANE1 DNAH5 DNAH3 CALM1 CALM2 CALM3 IFT57 CEP290 DNAI2 HYDIN CFAP46 | 1.93e-03 | 898 | 195 | 18 | GO:0005929 |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 1.96e-03 | 139 | 195 | 6 | GO:0097733 | |
| MousePheno | thin cerebral cortex | 1.57e-05 | 100 | 156 | 8 | MP:0006254 | |
| Domain | KRAB | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF705A ZNF317 ZNF705D ZNF284 ZNF705G ZNF45 ZNF74 ZNF705B ZNF222 | 8.94e-07 | 358 | 191 | 16 | PS50805 |
| Domain | KRAB | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF705A ZNF317 ZNF705D ZNF284 ZNF705G ZNF45 ZNF74 ZNF705B ZNF222 | 8.94e-07 | 358 | 191 | 16 | PF01352 |
| Domain | KRAB | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF705A ZNF317 ZNF705D ZNF284 ZNF705G ZNF45 ZNF74 ZNF705B ZNF222 | 1.33e-06 | 369 | 191 | 16 | SM00349 |
| Domain | KRAB | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF705A ZNF317 ZNF705D ZNF284 ZNF705G ZNF45 ZNF74 ZNF705B ZNF222 | 1.38e-06 | 370 | 191 | 16 | IPR001909 |
| Domain | GST_alpha | 1.04e-05 | 5 | 191 | 3 | IPR003080 | |
| Domain | Pept_S1A_FX | 1.04e-05 | 5 | 191 | 3 | IPR012224 | |
| Domain | AAA | 1.76e-05 | 144 | 191 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 1.76e-05 | 144 | 191 | 9 | IPR003593 | |
| Domain | EF-hand-dom_pair | MYL4 MYL6 CETN1 CETN2 SPTA1 LPCAT2 EHD1 PLCB2 CALM1 CALM3 TPPP PLCE1 | 4.15e-05 | 287 | 191 | 12 | IPR011992 |
| Domain | - | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF462 ZNF705A ZNF317 CHAMP1 ZNF705D ZNF284 ZNF705G ZNF45 ZNF74 ZNF705B PRDM16 ZNF222 | 7.17e-05 | 679 | 191 | 19 | 3.30.160.60 |
| Domain | - | MYL4 MYL6 CETN1 CETN2 SPTA1 LPCAT2 EHD1 PLCB2 CALM1 TPPP PLCE1 | 8.10e-05 | 261 | 191 | 11 | 1.10.238.10 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF462 ZNF705A ZNF317 CHAMP1 ZNF705D ZNF284 ZNF705G ZNF45 ZNF74 ZNF705B PRDM16 ZNF222 | 9.56e-05 | 694 | 191 | 19 | IPR013087 |
| Domain | Receptor_IA-2 | 1.04e-04 | 2 | 191 | 2 | PF11548 | |
| Domain | Receptor_IA-2_dom | 1.04e-04 | 2 | 191 | 2 | IPR021613 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.20e-04 | 10 | 191 | 3 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.20e-04 | 10 | 191 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.20e-04 | 10 | 191 | 3 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 1.20e-04 | 10 | 191 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.20e-04 | 10 | 191 | 3 | IPR020471 | |
| Domain | Elongated_TPR_rpt_dom | 1.64e-04 | 11 | 191 | 3 | IPR023114 | |
| Domain | Coagulation_fac_subgr_Gla_dom | 2.16e-04 | 12 | 191 | 3 | IPR017857 | |
| Domain | - | 2.16e-04 | 12 | 191 | 3 | 4.10.740.10 | |
| Domain | zf-C2H2 | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF462 ZNF705A ZNF317 CHAMP1 ZNF705D ZNF284 ZNF45 ZNF74 ZNF705B PRDM16 ZNF222 | 2.79e-04 | 693 | 191 | 18 | PF00096 |
| Domain | TPR_REGION | 3.02e-04 | 165 | 191 | 8 | PS50293 | |
| Domain | TPR | 3.02e-04 | 165 | 191 | 8 | PS50005 | |
| Domain | CHD_N | 3.10e-04 | 3 | 191 | 2 | IPR012958 | |
| Domain | CHD_C2 | 3.10e-04 | 3 | 191 | 2 | IPR012957 | |
| Domain | RESP18_dom | 3.10e-04 | 3 | 191 | 2 | IPR029403 | |
| Domain | VPS13 | 3.10e-04 | 3 | 191 | 2 | IPR026847 | |
| Domain | CHDCT2 | 3.10e-04 | 3 | 191 | 2 | PF08074 | |
| Domain | CHDNT | 3.10e-04 | 3 | 191 | 2 | PF08073 | |
| Domain | DUF1086 | 3.10e-04 | 3 | 191 | 2 | IPR009462 | |
| Domain | DUF1087 | 3.10e-04 | 3 | 191 | 2 | IPR009463 | |
| Domain | VPS13_mid_rpt | 3.10e-04 | 3 | 191 | 2 | PF16910 | |
| Domain | VPS13 | 3.10e-04 | 3 | 191 | 2 | PF16908 | |
| Domain | RESP18 | 3.10e-04 | 3 | 191 | 2 | PF14948 | |
| Domain | VPS13_N2 | 3.10e-04 | 3 | 191 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 3.10e-04 | 3 | 191 | 2 | IPR031642 | |
| Domain | DUF1087 | 3.10e-04 | 3 | 191 | 2 | PF06465 | |
| Domain | DUF1086 | 3.10e-04 | 3 | 191 | 2 | PF06461 | |
| Domain | DUF1087 | 3.10e-04 | 3 | 191 | 2 | SM01147 | |
| Domain | DUF1086 | 3.10e-04 | 3 | 191 | 2 | SM01146 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.53e-04 | 14 | 191 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.53e-04 | 14 | 191 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.53e-04 | 14 | 191 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.53e-04 | 14 | 191 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.53e-04 | 14 | 191 | 3 | IPR011704 | |
| Domain | GLA_1 | 3.53e-04 | 14 | 191 | 3 | PS00011 | |
| Domain | GLA_2 | 3.53e-04 | 14 | 191 | 3 | PS50998 | |
| Domain | Gla | 3.53e-04 | 14 | 191 | 3 | PF00594 | |
| Domain | MT | 3.53e-04 | 14 | 191 | 3 | PF12777 | |
| Domain | AAA_8 | 3.53e-04 | 14 | 191 | 3 | PF12780 | |
| Domain | GLA | 3.53e-04 | 14 | 191 | 3 | SM00069 | |
| Domain | GLA_domain | 3.53e-04 | 14 | 191 | 3 | IPR000294 | |
| Domain | AAA_5 | 3.53e-04 | 14 | 191 | 3 | PF07728 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF462 ZNF705A ZNF317 CHAMP1 ZNF705D ZNF284 ZNF705G ZNF45 ZNF74 ZNF705B PRDM16 ZNF222 | 3.88e-04 | 775 | 191 | 19 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF462 ZNF705A ZNF317 CHAMP1 ZNF705D ZNF284 ZNF705G ZNF45 ZNF74 ZNF705B PRDM16 ZNF222 | 4.01e-04 | 777 | 191 | 19 | PS00028 |
| Domain | DHC_fam | 4.38e-04 | 15 | 191 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 4.38e-04 | 15 | 191 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.38e-04 | 15 | 191 | 3 | IPR004273 | |
| Domain | - | 5.34e-04 | 16 | 191 | 3 | 3.20.20.100 | |
| Domain | Znf_C2H2-like | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF462 ZNF705A ZNF317 CHAMP1 ZNF705D ZNF284 ZNF705G ZNF45 ZNF74 ZNF705B PRDM16 ZNF222 | 5.38e-04 | 796 | 191 | 19 | IPR015880 |
| Domain | SHR-BD | 6.16e-04 | 4 | 191 | 2 | IPR009543 | |
| Domain | VPS13_C | 6.16e-04 | 4 | 191 | 2 | PF16909 | |
| Domain | VPS13_C | 6.16e-04 | 4 | 191 | 2 | IPR031645 | |
| Domain | SHR-BD | 6.16e-04 | 4 | 191 | 2 | PF06650 | |
| Domain | Znf_C2H2 | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF462 ZNF705A ZNF317 CHAMP1 ZNF705D ZNF284 ZNF705G ZNF45 ZNF74 ZNF705B PRDM16 ZNF222 | 6.16e-04 | 805 | 191 | 19 | IPR007087 |
| Domain | EF_HAND_2 | 6.38e-04 | 231 | 191 | 9 | PS50222 | |
| Domain | NADP_OxRdtase_dom | 6.44e-04 | 17 | 191 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 6.44e-04 | 17 | 191 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 6.44e-04 | 17 | 191 | 3 | IPR001395 | |
| Domain | ZnF_C2H2 | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF462 ZNF705A ZNF317 CHAMP1 ZNF705D ZNF284 ZNF705G ZNF45 ZNF74 ZNF705B PRDM16 ZNF222 | 6.44e-04 | 808 | 191 | 19 | SM00355 |
| Domain | EF_hand_dom | 6.58e-04 | 232 | 191 | 9 | IPR002048 | |
| Domain | ABC_transporter_CS | 8.75e-04 | 42 | 191 | 4 | IPR017871 | |
| Domain | TPR-contain_dom | 9.01e-04 | 150 | 191 | 7 | IPR013026 | |
| Domain | EF-hand_1 | 9.74e-04 | 152 | 191 | 7 | PF00036 | |
| Domain | P-loop_NTPase | CMPK1 ABCA3 ABCF1 GBP7 ATAD5 CFTR CHD3 CHD4 LONP1 EHD1 DNAH5 DYNC1H1 NLRP13 KIF13B DNAH3 KIF23 ARHGAP5 ABCE1 HYDIN | 1.14e-03 | 848 | 191 | 19 | IPR027417 |
| Domain | EFh | 1.22e-03 | 158 | 191 | 7 | SM00054 | |
| Domain | GST_N | 1.40e-03 | 22 | 191 | 3 | PF02798 | |
| Domain | GST_NTER | 1.40e-03 | 22 | 191 | 3 | PS50404 | |
| Domain | ABC_tran | 1.45e-03 | 48 | 191 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.45e-03 | 48 | 191 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.57e-03 | 49 | 191 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 1.69e-03 | 50 | 191 | 4 | IPR003439 | |
| Domain | TPR_2 | 1.69e-03 | 50 | 191 | 4 | PF07719 | |
| Domain | TPR_2 | 1.69e-03 | 50 | 191 | 4 | IPR013105 | |
| Domain | - | CMPK1 ABCA3 ABCF1 GBP7 ATAD5 CFTR CHD3 CHD4 LONP1 EHD1 DNAH5 DYNC1H1 NLRP13 DNAH3 ARHGAP5 ABCE1 HYDIN | 1.74e-03 | 746 | 191 | 17 | 3.40.50.300 |
| Domain | GST_C | 2.30e-03 | 26 | 191 | 3 | IPR004046 | |
| Domain | GST_C | 2.30e-03 | 26 | 191 | 3 | PF00043 | |
| Domain | TPR_1 | 2.31e-03 | 90 | 191 | 5 | IPR001440 | |
| Domain | TPR_1 | 2.31e-03 | 90 | 191 | 5 | PF00515 | |
| Domain | TPR_repeat | 2.48e-03 | 133 | 191 | 6 | IPR019734 | |
| Domain | Glutathione_S-Trfase_N | 2.57e-03 | 27 | 191 | 3 | IPR004045 | |
| Domain | Chorein_N | 2.80e-03 | 8 | 191 | 2 | PF12624 | |
| Domain | DHC_N1 | 2.80e-03 | 8 | 191 | 2 | PF08385 | |
| Domain | Calx_beta | 2.80e-03 | 8 | 191 | 2 | SM00237 | |
| Domain | VPS13_N | 2.80e-03 | 8 | 191 | 2 | IPR026854 | |
| Domain | Dynein_heavy_dom-1 | 2.80e-03 | 8 | 191 | 2 | IPR013594 | |
| Domain | Calx_beta | 3.57e-03 | 9 | 191 | 2 | IPR003644 | |
| Domain | Calx-beta | 3.57e-03 | 9 | 191 | 2 | PF03160 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 4.24e-07 | 28 | 151 | 6 | MM14711 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 8.39e-06 | 13 | 151 | 4 | MM15078 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.05e-05 | 71 | 151 | 7 | MM14491 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 1.16e-05 | 48 | 151 | 6 | MM14589 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.16e-05 | 14 | 151 | 4 | MM15052 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.19e-05 | 5 | 151 | 3 | MM14493 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.08e-05 | 16 | 151 | 4 | MM14492 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 2.35e-05 | 6 | 151 | 3 | MM14494 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 2.35e-05 | 6 | 151 | 3 | MM15662 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 4.09e-05 | 7 | 151 | 3 | MM1357 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 4.33e-05 | 19 | 151 | 4 | M47543 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 5.66e-05 | 39 | 151 | 5 | MM14496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 6.57e-05 | 21 | 151 | 4 | M47542 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 9.56e-05 | 23 | 151 | 4 | MM15222 | |
| Pathway | REACTOME_TRANSPORT_OF_GAMMA_CARBOXYLATED_PROTEIN_PRECURSORS_FROM_THE_ENDOPLASMIC_RETICULUM_TO_THE_GOLGI_APPARATUS | 9.65e-05 | 9 | 151 | 3 | MM14614 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_OF_PROTEIN_PRECURSORS | 9.65e-05 | 9 | 151 | 3 | MM14613 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 9.65e-05 | 9 | 151 | 3 | M3412 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.02e-04 | 44 | 151 | 5 | M39845 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 1.34e-04 | 25 | 151 | 4 | MM15574 | |
| Pathway | REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS | 1.37e-04 | 10 | 151 | 3 | M26977 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 1.37e-04 | 10 | 151 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 1.37e-04 | 10 | 151 | 3 | M47954 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 1.57e-04 | 26 | 151 | 4 | MM1346 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.57e-04 | 26 | 151 | 4 | MM14495 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.57e-04 | 26 | 151 | 4 | M27053 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 1.61e-04 | 76 | 151 | 6 | M9052 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 1.83e-04 | 27 | 151 | 4 | M14899 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.83e-04 | 27 | 151 | 4 | MM15053 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | 1.87e-04 | 11 | 151 | 3 | M12484 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 1.87e-04 | 11 | 151 | 3 | MM14810 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | 1.87e-04 | 11 | 151 | 3 | MM14615 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.87e-04 | 11 | 151 | 3 | M47958 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.12e-04 | 28 | 151 | 4 | M47508 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 2.44e-04 | 29 | 151 | 4 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 2.44e-04 | 29 | 151 | 4 | M13494 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 2.47e-04 | 12 | 151 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 2.47e-04 | 12 | 151 | 3 | MM15142 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 2.47e-04 | 12 | 151 | 3 | M47956 | |
| Pathway | BIOCARTA_EXTRINSIC_PATHWAY | 3.18e-04 | 13 | 151 | 3 | M4470 | |
| Pathway | BIOCARTA_EXTRINSIC_PATHWAY | 3.18e-04 | 13 | 151 | 3 | MM1395 | |
| Pathway | WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS | 3.18e-04 | 13 | 151 | 3 | M45518 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 3.60e-04 | 32 | 151 | 4 | MM15143 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 4.02e-04 | 14 | 151 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 4.02e-04 | 14 | 151 | 3 | M47388 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 4.02e-04 | 14 | 151 | 3 | MM1473 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 4.02e-04 | 14 | 151 | 3 | MM15391 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 4.99e-04 | 15 | 151 | 3 | M47385 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 4.99e-04 | 15 | 151 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 4.99e-04 | 15 | 151 | 3 | MM15103 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 4.99e-04 | 15 | 151 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 4.99e-04 | 15 | 151 | 3 | MM14795 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 5.12e-04 | 35 | 151 | 4 | MM15114 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 5.71e-04 | 36 | 151 | 4 | M1443 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 6.09e-04 | 16 | 151 | 3 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 6.09e-04 | 16 | 151 | 3 | M47449 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 6.62e-04 | 178 | 151 | 8 | M2890 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 7.34e-04 | 17 | 151 | 3 | M10066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 7.34e-04 | 17 | 151 | 3 | M47387 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 7.34e-04 | 17 | 151 | 3 | M47560 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 7.34e-04 | 17 | 151 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 7.34e-04 | 17 | 151 | 3 | MM1372 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 7.34e-04 | 17 | 151 | 3 | M2349 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 7.51e-04 | 101 | 151 | 6 | M1979 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 8.74e-04 | 18 | 151 | 3 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 8.74e-04 | 18 | 151 | 3 | M5290 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 8.74e-04 | 18 | 151 | 3 | MM15577 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 8.74e-04 | 18 | 151 | 3 | MM1385 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 8.74e-04 | 18 | 151 | 3 | M3430 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 1.03e-03 | 19 | 151 | 3 | M47809 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 1.03e-03 | 19 | 151 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 1.03e-03 | 19 | 151 | 3 | M47957 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.05e-03 | 191 | 151 | 8 | MM15586 | |
| Pathway | REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 1.12e-03 | 5 | 151 | 2 | M26948 | |
| Pathway | REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 1.12e-03 | 5 | 151 | 2 | MM14556 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.12e-03 | 109 | 151 | 6 | M18788 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.20e-03 | 20 | 151 | 3 | M15394 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.20e-03 | 20 | 151 | 3 | MM1445 | |
| Pathway | WP_JOUBERT_SYNDROME | 1.32e-03 | 76 | 151 | 5 | M39835 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.34e-03 | 45 | 151 | 4 | MM15040 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.35e-03 | 154 | 151 | 7 | MM15974 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.39e-03 | 21 | 151 | 3 | M11650 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.45e-03 | 156 | 151 | 7 | M39475 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 1.48e-03 | 115 | 151 | 6 | M9387 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.60e-03 | 22 | 151 | 3 | MM15104 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 1.60e-03 | 22 | 151 | 3 | MM15519 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 1.71e-03 | 48 | 151 | 4 | M26964 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 1.82e-03 | 23 | 151 | 3 | M47806 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.82e-03 | 23 | 151 | 3 | M47512 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 1.84e-03 | 49 | 151 | 4 | MM1442 | |
| Pathway | KEGG_GLUTATHIONE_METABOLISM | 1.99e-03 | 50 | 151 | 4 | M1840 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.00e-03 | 165 | 151 | 7 | MM15026 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 2.07e-03 | 24 | 151 | 3 | M47487 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.07e-03 | 24 | 151 | 3 | M47509 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 2.07e-03 | 24 | 151 | 3 | M751 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 2.14e-03 | 51 | 151 | 4 | M2288 | |
| Pathway | REACTOME_ESTROGEN_BIOSYNTHESIS | 2.31e-03 | 7 | 151 | 2 | MM14740 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 2.33e-03 | 25 | 151 | 3 | M1547 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 2.33e-03 | 25 | 151 | 3 | MM1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.33e-03 | 25 | 151 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.33e-03 | 25 | 151 | 3 | M47511 | |
| Pubmed | 1.09e-13 | 20 | 197 | 8 | 12743021 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ABCF1 UBAP2 MYL6 ATAD5 RSF1 FAM114A2 CHD3 CHD4 UNC45A TIPRL FKBP4 DNMT1 ANKS1A KIF23 WASHC2C NRBF2 ANK2 CALM1 NUP107 PUF60 ZCCHC8 SPAG9 IDH1 CHAMP1 CRABP2 ABCE1 KIAA1217 SENP6 AHNAK2 | 1.12e-13 | 934 | 197 | 29 | 33916271 |
| Pubmed | CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability. | 3.06e-10 | 8 | 197 | 5 | 16760425 | |
| Pubmed | Pathogenic NPHP5 mutations impair protein interaction with Cep290, a prerequisite for ciliogenesis. | 4.97e-09 | 5 | 197 | 4 | 23446637 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ABCF1 ORC3 CHD3 CHD4 HNRNPLL DYNC1H1 DNMT1 KIF23 WASHC2C CALM1 NUP107 CHAMP1 AHNAK2 SYMPK | 7.84e-09 | 332 | 197 | 14 | 32786267 |
| Pubmed | 1.48e-08 | 6 | 197 | 4 | 18694559 | ||
| Pubmed | CMPK1 ATAD5 ORC3 CETN2 RSF1 CHD3 CHD4 UNC45A LONP1 TAF4 HNRNPLL FKBP4 FKBP5 DNMT1 KIF23 PUF60 LMNB2 CHAMP1 COTL1 ABCE1 CNDP2 QSER1 SYMPK | 1.88e-08 | 1014 | 197 | 23 | 32416067 | |
| Pubmed | 3.45e-08 | 7 | 197 | 4 | 8617494 | ||
| Pubmed | PDE4B UBAP2 CHD4 ZNF462 STRN PTPRN2 TAF4 DYNC1H1 DNMT1 ANKS1A KIF13B KIF23 ANK2 CALM1 CALM2 TPPP LMNB2 CIT KIAA1217 BRD7 RIMBP2 QSER1 | 3.46e-08 | 963 | 197 | 22 | 28671696 | |
| Pubmed | ATAD5 TIPRL CEP350 USP31 LONP1 PTPRN PTPRN2 VPS13A USP12 FKBP4 FKBP5 DNMT1 NUP107 CALM2 CALM3 IFT57 CIP2A CEP290 SPAG9 PCF11 PDIA4 ARHGAP5 SYMPK | 3.49e-08 | 1049 | 197 | 23 | 27880917 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CMPK1 ABCF1 MYL6 TRIM4 SPTA1 CHD4 NAA35 FKBP4 DYNC1H1 FLNC PUF60 HNRNPA3 IDH1 CPT1A CRABP2 PDIA4 ABCE1 CNDP2 HYDIN AHNAK2 | 4.06e-08 | 807 | 197 | 20 | 30575818 |
| Pubmed | ABCF1 RSF1 CHD4 LONP1 FKBP4 DYNC1H1 DNMT1 FLNC KIF23 NUP107 PUF60 ZCCHC8 HNRNPA3 SPAG9 LMNB2 PDIA4 ABCE1 SYMPK | 4.13e-08 | 653 | 197 | 18 | 22586326 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | CMPK1 PDE4D ACAT2 CHD3 CNTLN AGT AKR1B10 CPLANE1 FKBP4 SH3BGRL2 NRDC PUF60 HNRNPA3 LMNB2 IDH1 CRABP2 CIT ABCE1 KIAA1217 | 4.40e-08 | 732 | 197 | 19 | 34732716 |
| Pubmed | ABCF1 MYL6 TRIM4 ORC3 INPP5D ZNF184 CHD3 CHD4 TIPRL JUND TAF4 HNRNPLL FKBP4 FKBP5 DYNC1H1 DNMT1 PUF60 HNRNPA3 CIT PCF11 PDIA4 ABCE1 QSER1 | 8.59e-08 | 1103 | 197 | 23 | 34189442 | |
| Pubmed | MYL6 TRIM4 RSF1 CHD3 ZNF462 DNMT1 ANKS1A NUP107 ZCCHC8 CEP290 PARP14 CCDC141 CRABP2 BRD7 HYDIN | 8.76e-08 | 469 | 197 | 15 | 27634302 | |
| Pubmed | UBAP2 MYL6 CETN2 ZNF184 CHD3 CHD4 UNC45A ZNF462 CLPTM1L JUND KIF23 WASHC2C NUP107 PUF60 ZCCHC8 HNRNPA3 CPT1A PCF11 ARHGAP5 SYMPK | 8.88e-08 | 847 | 197 | 20 | 35850772 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DOCK4 ABCF1 MYL6 UNC45A CNTLN CEP350 STRN LONP1 HROB CPLANE1 FKBP4 DYNC1H1 ANKS1A WASHC2C CIP2A CEP290 RGS12 FAM83B ARHGAP5 KIAA1217 | 9.95e-08 | 853 | 197 | 20 | 28718761 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ABCF1 UBE4B CHD3 CHD4 JUND DBF4 FKBP5 DNMT1 ANKS1A KIF23 WASHC2C ZCCHC8 SPAG9 CHAMP1 PCF11 SHCBP1 SENP6 CYTH4 SYMPK | 1.05e-07 | 774 | 197 | 19 | 15302935 |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 29932249 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 18370588 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 1.79e-07 | 3 | 197 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 1.79e-07 | 3 | 197 | 3 | 9923700 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 1.79e-07 | 3 | 197 | 3 | 23893133 | |
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 1.79e-07 | 3 | 197 | 3 | 8573130 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 10899953 | ||
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 1.79e-07 | 3 | 197 | 3 | 9278050 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 15719022 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 1.79e-07 | 3 | 197 | 3 | 11847276 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 10416864 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 7828884 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 8862395 | ||
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 1.79e-07 | 3 | 197 | 3 | 2469574 | |
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 1.79e-07 | 3 | 197 | 3 | 15632291 | |
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 1.79e-07 | 3 | 197 | 3 | 8631777 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 18553937 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 14978283 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 1.79e-07 | 3 | 197 | 3 | 11054265 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 33191766 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 18940602 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 25268113 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 19651602 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 26969752 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 1.79e-07 | 3 | 197 | 3 | 11807546 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 8312049 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 37380439 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 31628181 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 1.79e-07 | 3 | 197 | 3 | 11710561 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 1.79e-07 | 3 | 197 | 3 | 9362478 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 12093480 | ||
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 1.79e-07 | 3 | 197 | 3 | 3384819 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 21799007 | ||
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 1.79e-07 | 3 | 197 | 3 | 20956522 | |
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 1.79e-07 | 3 | 197 | 3 | 18786401 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 11072229 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 16229872 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 15063758 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 8226798 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 9658102 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 1.79e-07 | 3 | 197 | 3 | 17582331 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | UBAP2 MYL6 CETN1 CETN2 CHD4 UNC45A F7 STRN LONP1 USP12 KLHL18 FKBP5 DNMT1 KIF13B FLNC CALM1 NRDC CERT1 ABCE1 SHCBP1 RIMBP2 | 3.15e-07 | 1005 | 197 | 21 | 19615732 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ATAD5 ZNF184 RSF1 CHD3 CHD4 ZNF226 ZNF462 FSIP2 TAF4 DNMT1 KIF23 CHAMP1 BRD7 SENP6 PAX6 QSER1 | 4.46e-07 | 608 | 197 | 16 | 36089195 |
| Pubmed | UBAP2 ATAD5 CHD3 ZNF462 JUND LONP1 USP12 TAF4 FKBP4 DYNC1H1 TMED1 KIF23 CALM1 NUP107 CALM2 SPAG9 CIT ZNF284 PCF11 PDIA4 BRD7 PAX6 QSER1 PRDM16 SYMPK | 6.13e-07 | 1429 | 197 | 25 | 35140242 | |
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 7.13e-07 | 4 | 197 | 3 | 7607248 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 27516456 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 30842726 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 7.13e-07 | 4 | 197 | 3 | 23040497 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 16299511 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 25437912 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 17046994 | ||
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 7.13e-07 | 4 | 197 | 3 | 15499021 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 10692436 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 16478480 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 21167176 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 7.13e-07 | 4 | 197 | 3 | 16127172 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 20226167 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 10823944 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 7.13e-07 | 4 | 197 | 3 | 25519244 | |
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 7.13e-07 | 4 | 197 | 3 | 14960328 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 22405011 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 7.13e-07 | 4 | 197 | 3 | 29724949 | |
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 7.13e-07 | 4 | 197 | 3 | 11807557 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 11286509 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 20953164 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 19855925 | ||
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 7.13e-07 | 4 | 197 | 3 | 14594800 | |
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 7.13e-07 | 4 | 197 | 3 | 16338416 | |
| Pubmed | Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. | 7.13e-07 | 4 | 197 | 3 | 8780394 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 19279214 | ||
| Pubmed | Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. | 7.13e-07 | 4 | 197 | 3 | 10625668 | |
| Pubmed | Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. | 7.13e-07 | 4 | 197 | 3 | 20103772 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 9096366 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 12577052 | ||
| Pubmed | FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. | 7.13e-07 | 4 | 197 | 3 | 22067155 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 25441029 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 16505387 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 26164367 | ||
| Interaction | NAA40 interactions | ABCF1 UBAP2 MYL6 ATAD5 CETN2 RSF1 FAM114A2 CHD3 CHD4 UNC45A TIPRL FKBP4 DNMT1 ANKS1A KIF23 WASHC2C NRBF2 ANK2 CALM1 NUP107 PUF60 ZCCHC8 SPAG9 IDH1 CHAMP1 CRABP2 CIT ABCE1 KIAA1217 SENP6 AHNAK2 | 4.14e-09 | 978 | 193 | 31 | int:NAA40 |
| Interaction | PPEF2 interactions | 2.82e-07 | 29 | 193 | 6 | int:PPEF2 | |
| Interaction | TMPRSS6 interactions | 1.64e-06 | 10 | 193 | 4 | int:TMPRSS6 | |
| Interaction | WDR5 interactions | ABCF1 UBAP2 MYL6 CHD3 CHD4 UNC45A ZNF462 LONP1 EHD1 UGDH TAF4 DYNC1H1 DNMT1 KIF23 NUP107 PUF60 HNRNPA3 SPAG9 LMNB2 IDH1 PARP14 CIT PDIA4 ABCE1 SETBP1 CNDP2 ALDH4A1 SYMPK | 2.22e-06 | 1101 | 193 | 28 | int:WDR5 |
| Interaction | CAMKK2 interactions | 4.33e-06 | 69 | 193 | 7 | int:CAMKK2 | |
| Interaction | SOX2 interactions | CMPK1 PDE4D ACAT2 ATAD5 CETN2 CHD3 CHD4 CNTLN ZNF462 JUND LONP1 AGT AKR1B10 CPLANE1 FKBP4 SH3BGRL2 KIF23 NRDC PUF60 ZCCHC8 HNRNPA3 LMNB2 IDH1 CHAMP1 CRABP2 CIT ABCE1 KIAA1217 SHCBP1 BRD7 PAX6 QSER1 | 5.18e-06 | 1422 | 193 | 32 | int:SOX2 |
| Interaction | IQGAP3 interactions | 8.87e-06 | 141 | 193 | 9 | int:IQGAP3 | |
| Interaction | TRIM28 interactions | ABCF1 UBE4B CFTR ZNF184 RSF1 CHD3 CHD4 ZNF223 ZNF226 CNPY2 ZNF229 ZNF235 ZNF462 TAF4 DNAH5 HNRNPLL FKBP4 FKBP5 DYNC1H1 DNMT1 KIF13B ZCCHC8 ZNF317 CHAMP1 CIT ZNF284 ABCE1 ZNF45 BRD7 CNDP2 ZNF74 ALDH4A1 | 1.08e-05 | 1474 | 193 | 32 | int:TRIM28 |
| Interaction | MYO9B interactions | 1.33e-05 | 113 | 193 | 8 | int:MYO9B | |
| Interaction | MREG interactions | 1.36e-05 | 16 | 193 | 4 | int:MREG | |
| Interaction | YWHAB interactions | DOCK4 PDE4B CFTR CNTLN TESPA1 CEP350 USP31 USP12 PPIE DYNC1H1 ANKS1A PITHD1 KIF13B KIF23 CALM1 NUP107 ZCCHC8 RGS12 C6orf132 FAM83B PDIA4 VPS13D SLC8A3 SHCBP1 AHNAK2 | 1.39e-05 | 1014 | 193 | 25 | int:YWHAB |
| Interaction | CBX3 interactions | ATAD5 ORC3 ZNF184 RSF1 CHD3 CHD4 ZNF226 ZNF462 TAF4 FKBP4 DNMT1 KIF23 IDH1 CHAMP1 CIT ABCE1 SHCBP1 SENP6 PRDM16 | 1.52e-05 | 646 | 193 | 19 | int:CBX3 |
| Interaction | MEN1 interactions | UBAP2 UBE4B CETN2 CFTR ZNF184 CHD3 CHD4 UNC45A ZNF462 CLPTM1L JUND DBF4 UGDH KIF13B KIF23 WASHC2C NUP107 ZCCHC8 PARP14 CHAMP1 PCF11 ARHGAP5 SETBP1 QSER1 SYMPK | 1.78e-05 | 1029 | 193 | 25 | int:MEN1 |
| Interaction | PHLPP1 interactions | ABCF1 UBAP2 CHD3 UNC45A USP12 FKBP4 FKBP5 DYNC1H1 KIF23 CIP2A COTL1 KIAA1217 AHNAK2 | 2.06e-05 | 333 | 193 | 13 | int:PHLPP1 |
| Interaction | PCNT interactions | CETN1 CHD3 CHD4 CEP350 ADCY4 CALM1 CALM2 CALM3 CEP290 BRD7 PAX6 | 2.19e-05 | 241 | 193 | 11 | int:PCNT |
| Interaction | SPATA17 interactions | 2.94e-05 | 7 | 193 | 3 | int:SPATA17 | |
| Interaction | CALM1 interactions | MYL6 CETN1 CETN2 CFTR STRN VPS13A HNRNPLL FKBP4 KIF23 CALM1 CALM2 CEP290 IDH1 CIT FAM83B PDIA4 VPS13D QSER1 | 3.46e-05 | 626 | 193 | 18 | int:CALM1 |
| Interaction | POC5 interactions | 3.60e-05 | 95 | 193 | 7 | int:POC5 | |
| Interaction | PRNP interactions | DOCK4 MYL6 ZNF155 RSF1 TIPRL CEP350 STRN LONP1 EHD1 TAF4 CRYZL1 FKBP4 SH3BGRL2 PITHD1 DPP6 FLNC COL12A1 ANK2 CIP2A MTERF3 CEP290 HNRNPA3 LMNB2 CIT SHCBP1 SYMPK | 4.58e-05 | 1158 | 193 | 26 | int:PRNP |
| Interaction | KCNN1 interactions | 4.67e-05 | 8 | 193 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 4.67e-05 | 8 | 193 | 3 | int:ARPP21 | |
| Interaction | ZNF112 interactions | 4.67e-05 | 8 | 193 | 3 | int:ZNF112 | |
| Interaction | IQGAP1 interactions | MYL4 MYL6 CFTR CHD3 CHD4 PPIE DYNC1H1 KIF23 CALM1 NRDC CALM2 CALM3 SPAG9 CIT ABCE1 BRD7 PRDM16 | 5.72e-05 | 591 | 193 | 17 | int:IQGAP1 |
| Interaction | SUMO2 interactions | ABCF1 ORC3 CHD3 CHD4 PPIE HNRNPLL DYNC1H1 DNMT1 KIF23 WASHC2C CALM1 NUP107 CHAMP1 PDIA4 SENP6 AHNAK2 SYMPK | 5.72e-05 | 591 | 193 | 17 | int:SUMO2 |
| Interaction | PDIA3 interactions | CFTR FSIP2 PTPRN PPIE KIF13B KIF23 COL12A1 CALM1 HNRNPA3 PDIA4 CD1B ABCE1 CNDP2 HYDIN SOS2 | 5.75e-05 | 476 | 193 | 15 | int:PDIA3 |
| Interaction | DDX49 interactions | 6.60e-05 | 72 | 193 | 6 | int:DDX49 | |
| Interaction | GSTA5 interactions | 6.96e-05 | 9 | 193 | 3 | int:GSTA5 | |
| Interaction | TERF2IP interactions | ATAD5 ORC3 RSF1 CHD3 AKR1B10 TAF4 DNMT1 KIF23 PUF60 ZCCHC8 CHAMP1 COTL1 PCF11 SENP6 QSER1 SYMPK | 8.70e-05 | 552 | 193 | 16 | int:TERF2IP |
| Interaction | AGR2 interactions | CMPK1 ABCF1 MYL6 TRIM4 SPTA1 CHD4 NAA35 AKR1B10 FKBP4 DYNC1H1 FLNC PUF60 HNRNPA3 IDH1 CPT1A CRABP2 PDIA4 ABCE1 BRD7 CNDP2 HYDIN AHNAK2 | 9.28e-05 | 934 | 193 | 22 | int:AGR2 |
| Interaction | IQCG interactions | 9.88e-05 | 10 | 193 | 3 | int:IQCG | |
| Interaction | GSTA2 interactions | 9.88e-05 | 10 | 193 | 3 | int:GSTA2 | |
| Interaction | SPTBN4 interactions | 1.14e-04 | 50 | 193 | 5 | int:SPTBN4 | |
| Interaction | YWHAH interactions | DOCK4 UBAP2 CFTR UNC45A TESPA1 CEP350 USP31 USP12 DNMT1 ANKS1A KIF13B KIF23 ZCCHC8 CEP290 FSD1 RGS12 C6orf132 FAM83B PDIA4 VPS13D ABCE1 KIAA1217 SHCBP1 AHNAK2 | 1.46e-04 | 1102 | 193 | 24 | int:YWHAH |
| Interaction | EWSR1 interactions | MYL6 CFTR ZNF184 RSF1 FAM114A2 CHD3 CHD4 AGT PPIE TAF4 FKBP4 NRBF2 CALM1 PUF60 ZCCHC8 HNRNPA3 PCF11 PDIA4 ABCE1 BRD7 ABTB1 | 1.68e-04 | 906 | 193 | 21 | int:EWSR1 |
| Interaction | CORIN interactions | 1.79e-04 | 12 | 193 | 3 | int:CORIN | |
| Interaction | GSTA4 interactions | 1.79e-04 | 12 | 193 | 3 | int:GSTA4 | |
| Interaction | DENND4A interactions | 2.28e-04 | 90 | 193 | 6 | int:DENND4A | |
| Interaction | C11orf65 interactions | 2.30e-04 | 13 | 193 | 3 | int:C11orf65 | |
| Interaction | SGSM2 interactions | 2.38e-04 | 32 | 193 | 4 | int:SGSM2 | |
| Interaction | SFI1 interactions | 2.38e-04 | 32 | 193 | 4 | int:SFI1 | |
| Interaction | TWIST1 interactions | 2.39e-04 | 170 | 193 | 8 | int:TWIST1 | |
| Cytoband | 6p12.1 | 1.22e-05 | 33 | 197 | 4 | 6p12.1 | |
| Cytoband | 19q13.2 | 8.12e-05 | 164 | 197 | 6 | 19q13.2 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF155 ZNF184 ZNF223 ZNF225 ZNF226 ZNF229 ZNF235 ZNF462 ZNF705A ZNF317 CHAMP1 ZNF705D ZNF284 ZNF705G ZNF45 ZNF74 ZNF705B PRDM16 ZNF222 | 2.84e-06 | 718 | 140 | 19 | 28 |
| GeneFamily | EF-hand domain containing | 8.06e-06 | 219 | 140 | 10 | 863 | |
| GeneFamily | Gla domain containing | 1.23e-04 | 13 | 140 | 3 | 1250 | |
| GeneFamily | Aldo-keto reductases | 1.93e-04 | 15 | 140 | 3 | 399 | |
| GeneFamily | Dyneins, axonemal | 2.85e-04 | 17 | 140 | 3 | 536 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 5.46e-04 | 21 | 140 | 3 | 813 | |
| GeneFamily | Glutathione S-transferases | 9.22e-04 | 25 | 140 | 3 | 567 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.01e-03 | 115 | 140 | 5 | 769 | |
| GeneFamily | PHD finger proteins|NuRD complex | 3.73e-03 | 12 | 140 | 2 | 1305 | |
| Coexpression | MURARO_PANCREAS_ALPHA_CELL | AHI1 PDE4D MYL6 KLHL41 CNPY2 GCNT1 F10 PTPRN PTPRN2 AGT FAM47E DPP6 CALM1 COTL1 GSTA4 RIMBP2 PAX6 PLCE1 | 2.24e-07 | 568 | 192 | 18 | M39168 |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | GBP7 SPTA1 ZNF184 FAM13B STRN CPLANE1 DNAH5 PARP14 ADGRG6 SOS2 | 2.37e-06 | 200 | 192 | 10 | M7776 |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 6.16e-06 | 17 | 192 | 4 | MM686 | |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 8.00e-06 | 181 | 192 | 9 | M39225 | |
| Coexpression | FISCHER_DREAM_TARGETS | AHI1 ATAD5 ORC3 ZNF184 SFR1 JUND LONP1 HROB DBF4 FKBP5 DNMT1 KIF23 NUP107 CIP2A HNRNPA3 SPAG9 CIT PCF11 ABCE1 ZNF45 SHCBP1 | 9.59e-06 | 969 | 192 | 21 | M149 |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | ATG4A UBE4B ZNF225 ZNF226 UGDH KLHL18 FKBP5 ANKS1A ENGASE NRBF2 MTERF3 CPT1A PCF11 ZNF45 | 1.24e-05 | 477 | 192 | 14 | M40930 |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | CETN2 NAA35 PTPRN2 UGDH PPIE FAM47E DNAH5 DNAH3 CALM1 CALM2 CALM3 IFT57 CEP290 NSUN7 C6orf132 GSTA1 GSTA2 DNAI2 CNDP2 HYDIN CFAP46 AHNAK2 | 1.83e-05 | 1093 | 192 | 22 | M41649 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | ACAT2 FAM13B DBF4 UGDH HNRNPLL NUP107 CALM2 ZCCHC8 HNRNPA3 ZNF317 TMTC4 SHCBP1 BRD7 | 2.06e-05 | 434 | 192 | 13 | M15150 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | CEP350 SH3TC1 PLCB2 PPIE TAF4 FKBP5 ANKS1A ENGASE CALM1 ADGRG6 SYMPK SOS2 | 2.45e-05 | 378 | 192 | 12 | M41174 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | TGIF2 ATAD5 HROB DBF4 TAF4 DNMT1 ANKS1A KIF23 NUP107 CIP2A LMNB2 CIT ADGRG6 SNX25 SHCBP1 | 2.55e-05 | 578 | 192 | 15 | M2368 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | ACAT2 FAM13B DBF4 UGDH HNRNPLL NUP107 CALM2 ZCCHC8 HNRNPA3 ZNF317 TMTC4 SHCBP1 BRD7 | 2.87e-05 | 448 | 192 | 13 | MM1044 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | TGIF2 ATAD5 HROB DBF4 TAF4 DNMT1 ANKS1A KIF23 NUP107 CIP2A LMNB2 CIT ADGRG6 SNX25 SHCBP1 | 3.69e-05 | 597 | 192 | 15 | MM1309 |
| Coexpression | PURWIN_A375_MEWO_COMMON_SOX10_TARGETS | 5.74e-05 | 29 | 192 | 4 | M48226 | |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_24HR_UP | MYL6 ACAT2 CNPY2 DBF4 FKBP4 DNMT1 KIF23 WASHC2C CALM1 NUP107 HNRNPA3 LMNB2 COTL1 SHCBP1 | 7.24e-05 | 561 | 192 | 14 | M1463 |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | CHD4 CEP350 JUND STRN AKR1B10 KLHL18 CALM1 CALM2 ZCCHC8 SPAG9 CPT1A FAM83B AKR1B15 B4GALNT2 | 8.26e-05 | 568 | 192 | 14 | MM3824 |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN | 1.04e-04 | 196 | 192 | 8 | M5008 | |
| Coexpression | RATTENBACHER_BOUND_BY_CELF1 | MYL4 FAM13B F7 JUND STRN SH3TC1 PTPRN2 HNRNPA3 FAM83B KIAA1217 PRDM16 HYDIN | 1.14e-04 | 444 | 192 | 12 | M2505 |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN | 1.15e-04 | 199 | 192 | 8 | M9418 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN | 1.15e-04 | 199 | 192 | 8 | M3795 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_B_CELL_AGEING | 1.18e-04 | 315 | 192 | 10 | MM3784 | |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 1.19e-04 | 200 | 192 | 8 | M9484 | |
| Coexpression | GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 1.19e-04 | 200 | 192 | 8 | M9549 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP | 1.19e-04 | 200 | 192 | 8 | M9922 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 1.19e-04 | 200 | 192 | 8 | M6096 | |
| Coexpression | GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN | 1.19e-04 | 200 | 192 | 8 | M9055 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.19e-04 | 200 | 192 | 8 | M9135 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | ATAD5 FKBP4 FKBP5 DNMT1 KIF23 COL12A1 NUP107 CIP2A CIT SHCBP1 | 1.44e-04 | 323 | 192 | 10 | M2156 |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_UNSPECIFIED | 1.53e-04 | 37 | 192 | 4 | M39292 | |
| Coexpression | BUSSLINGER_DUODENAL_EARLY_IMMATURE_ENTEROCYTES | 1.89e-04 | 113 | 192 | 6 | M40027 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_CLASSICAL | 1.91e-04 | 161 | 192 | 7 | M2121 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | AHI1 ABCF1 ATAD5 ORC3 ZNF184 RSF1 DAB1 CHD4 CNTLN CEP350 ZNF462 NAA35 DBF4 VPS13A CPLANE1 DNMT1 HSCB ANK2 NRDC CIP2A CEP290 CIT GSTA1 ARHGAP5 SETBP1 BRD7 QSER1 PRDM16 | 4.96e-06 | 1257 | 186 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | AHI1 ABCF1 ATAD5 ORC3 ZNF184 RSF1 DAB1 CHD4 ADGRV1 CNTLN CEP350 ZNF462 NAA35 DBF4 VPS13A CPLANE1 DNMT1 HSCB ANK2 NRDC CIP2A CEP290 CIT GSTA1 ARHGAP5 SETBP1 BRD7 QSER1 PRDM16 | 2.84e-05 | 1459 | 186 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-07 | 184 | 197 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-07 | 184 | 197 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-07 | 184 | 197 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 6.81e-07 | 163 | 197 | 8 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.95e-07 | 169 | 197 | 8 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.84e-06 | 186 | 197 | 8 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.91e-06 | 187 | 197 | 8 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 187 | 197 | 8 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.99e-06 | 188 | 197 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 190 | 197 | 8 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.24e-06 | 191 | 197 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.24e-06 | 191 | 197 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-06 | 192 | 197 | 8 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.33e-06 | 192 | 197 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.51e-06 | 194 | 197 | 8 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.61e-06 | 195 | 197 | 8 | 6365e3893e38231090ec2dbef010dec71dea3d07 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.71e-06 | 196 | 197 | 8 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.71e-06 | 196 | 197 | 8 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.82e-06 | 197 | 197 | 8 | 32484fb5dde0a4525dd8028dde01ca5a4e51e4b6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.15e-06 | 200 | 197 | 8 | 80e0483d5ab0c6213aae0ec62619f57e6ec0e4c2 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.15e-06 | 200 | 197 | 8 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | mild-B_intermediate|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.15e-06 | 200 | 197 | 8 | 8e3132a1fe3708f725c5c4077878fb87bbea3678 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.15e-06 | 200 | 197 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.35e-06 | 142 | 197 | 7 | 1e57c75e9f28aae2ca99543448433fa7326398ad | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-06 | 143 | 197 | 7 | 0cd332c128710291a39957d3da22953352f5c382 | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 146 | 197 | 7 | 24e63124116b9a6796ae0495fc69dc6b6af28c38 | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 146 | 197 | 7 | ae43d418492177546b7f85afffb4287d40815f88 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 5.02e-06 | 151 | 197 | 7 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-06 | 160 | 197 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-06 | 160 | 197 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | control-Epithelial-Ciliated-diff|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.65e-06 | 161 | 197 | 7 | ef4b946914a4e2727ed57362dc6965c299520f35 | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.35e-06 | 166 | 197 | 7 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.35e-06 | 166 | 197 | 7 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | control-Epithelial-Ciliated-diff|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.09e-05 | 170 | 197 | 7 | 334c4103eb6e021766f5638a4ab14b59ad085ac7 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.18e-05 | 172 | 197 | 7 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-05 | 177 | 197 | 7 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-05 | 179 | 197 | 7 | ac987c9425a1b4106d1b8779a2c5461383eae2ae | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.52e-05 | 179 | 197 | 7 | 6718cadcc2d3b64717ed84244ef1242d392662dc | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-05 | 180 | 197 | 7 | a682a5d55c612709c9ee9fa4289d6f8bef7fe1af | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.64e-05 | 181 | 197 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 182 | 197 | 7 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 182 | 197 | 7 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.76e-05 | 183 | 197 | 7 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.89e-05 | 185 | 197 | 7 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.89e-05 | 185 | 197 | 7 | 6aeae77a087d695b1e58c5f63265e7113aa2e343 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.95e-05 | 186 | 197 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 2.02e-05 | 187 | 197 | 7 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.02e-05 | 187 | 197 | 7 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.02e-05 | 187 | 197 | 7 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-05 | 187 | 197 | 7 | e61992de4f98eeea08b43213850769d923f8db48 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.09e-05 | 188 | 197 | 7 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 2.09e-05 | 188 | 197 | 7 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.09e-05 | 188 | 197 | 7 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.09e-05 | 188 | 197 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 2.16e-05 | 189 | 197 | 7 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 189 | 197 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-05 | 189 | 197 | 7 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.16e-05 | 189 | 197 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.24e-05 | 190 | 197 | 7 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.24e-05 | 190 | 197 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 191 | 197 | 7 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 2.31e-05 | 191 | 197 | 7 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 191 | 197 | 7 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 191 | 197 | 7 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.31e-05 | 191 | 197 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.31e-05 | 191 | 197 | 7 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.31e-05 | 191 | 197 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 2.31e-05 | 191 | 197 | 7 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 192 | 197 | 7 | 86d792682ba51696f503c79625dd20f87bcf651f | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.39e-05 | 192 | 197 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.39e-05 | 192 | 197 | 7 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.39e-05 | 192 | 197 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.39e-05 | 192 | 197 | 7 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 192 | 197 | 7 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | ASK428-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.39e-05 | 192 | 197 | 7 | 356ebddd03aec341b79890977edb8ff0804999a1 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.39e-05 | 192 | 197 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 192 | 197 | 7 | d0ad6a205ad50a3c523fa68676996b289eabc5de | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.39e-05 | 192 | 197 | 7 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.47e-05 | 193 | 197 | 7 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.47e-05 | 193 | 197 | 7 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.47e-05 | 193 | 197 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.47e-05 | 193 | 197 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 193 | 197 | 7 | f597fefc54327a1ad136e2f66b6e81cc5c761eb7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.47e-05 | 193 | 197 | 7 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.47e-05 | 193 | 197 | 7 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.47e-05 | 193 | 197 | 7 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.47e-05 | 193 | 197 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 2.47e-05 | 193 | 197 | 7 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-05 | 193 | 197 | 7 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-05 | 194 | 197 | 7 | 3cd90d01ed5a5ce65aad8284dab2537ec16e3d7c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-05 | 194 | 197 | 7 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.56e-05 | 194 | 197 | 7 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-05 | 194 | 197 | 7 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | critical-Epithelial-Ciliated-diff|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.56e-05 | 194 | 197 | 7 | 176090949b53c043c58df63ad8cf4f486b350bdc | |
| ToppCell | (3)_Chondrocytes-(33)_Chondro-prol/rest|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.56e-05 | 194 | 197 | 7 | 4a207630d72059345b10010f5cfd3b1462458324 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.56e-05 | 194 | 197 | 7 | 74d588de2f84a4ef112fd642f7e112a542d5ef11 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.64e-05 | 195 | 197 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-05 | 195 | 197 | 7 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-05 | 195 | 197 | 7 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.64e-05 | 195 | 197 | 7 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| Drug | trequinsin | 2.84e-08 | 58 | 191 | 8 | CID000005537 | |
| Drug | propyl-methylenedioxyindene | 7.11e-08 | 6 | 191 | 4 | CID000145934 | |
| Drug | asocainol | 1.65e-07 | 7 | 191 | 4 | CID000071161 | |
| Drug | Org 9935 | 2.25e-07 | 17 | 191 | 5 | CID000131100 | |
| Drug | perhexiline | 5.49e-07 | 58 | 191 | 7 | CID000004746 | |
| Drug | milrinone | 5.77e-07 | 150 | 191 | 10 | CID000004197 | |
| Drug | NSC366363 | 5.81e-07 | 3 | 191 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 5.81e-07 | 3 | 191 | 3 | CID004630710 | |
| Drug | tatsiensine | 5.81e-07 | 3 | 191 | 3 | CID000163526 | |
| Drug | delcosine | 5.81e-07 | 3 | 191 | 3 | CID000120726 | |
| Drug | denbufylline | 1.47e-06 | 24 | 191 | 5 | CID000002984 | |
| Drug | 4-iodotamoxifen | 1.51e-06 | 11 | 191 | 4 | CID003037006 | |
| Drug | tBuBHQ | 1.82e-06 | 69 | 191 | 7 | CID000002374 | |
| Drug | Nsc642900 | 2.31e-06 | 4 | 191 | 3 | CID000498959 | |
| Drug | CTK0F9956 | 2.31e-06 | 4 | 191 | 3 | CID011779542 | |
| Drug | 85318-25-8 | 2.31e-06 | 4 | 191 | 3 | CID006439702 | |
| Drug | cloxacepride | 2.31e-06 | 4 | 191 | 3 | CID000068859 | |
| Drug | chloraniformethan | 2.31e-06 | 4 | 191 | 3 | CID000030331 | |
| Drug | Ti 233 | 2.31e-06 | 4 | 191 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 2.31e-06 | 4 | 191 | 3 | CID000080867 | |
| Drug | herbarumin III | 2.31e-06 | 4 | 191 | 3 | CID000643678 | |
| Drug | thiomethylpromazine | 2.31e-06 | 4 | 191 | 3 | CID000070583 | |
| Drug | KS-504e | 2.31e-06 | 4 | 191 | 3 | CID000129559 | |
| Drug | KS-504d | 2.31e-06 | 4 | 191 | 3 | CID000129557 | |
| Drug | estradiol, norethindrone drug combination | 2.31e-06 | 4 | 191 | 3 | ctd:C418365 | |
| Drug | Archanagelicine | 2.31e-06 | 4 | 191 | 3 | CID003083773 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 2.31e-06 | 4 | 191 | 3 | CID000127194 | |
| Drug | Roylin | 2.31e-06 | 4 | 191 | 3 | CID000099924 | |
| Drug | KS-502 | 2.31e-06 | 4 | 191 | 3 | CID000129242 | |
| Drug | KS-501 | 2.31e-06 | 4 | 191 | 3 | CID000129240 | |
| Drug | 2'-methoxykobusin | 2.31e-06 | 4 | 191 | 3 | CID000637889 | |
| Drug | PS-990 | 2.31e-06 | 4 | 191 | 3 | CID000157810 | |
| Drug | papaverine | 2.48e-06 | 176 | 191 | 10 | CID000004680 | |
| Drug | SC-52458 | 3.23e-06 | 13 | 191 | 4 | CID000132706 | |
| Drug | P-81 | 4.50e-06 | 14 | 191 | 4 | CID000052396 | |
| Drug | jujubogenin | 5.74e-06 | 5 | 191 | 3 | CID005318721 | |
| Drug | D 890 | 5.74e-06 | 5 | 191 | 3 | CID000134083 | |
| Drug | NSC-36360 | 5.74e-06 | 5 | 191 | 3 | CID000133340 | |
| Drug | alpha-CAO | 5.74e-06 | 5 | 191 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 5.74e-06 | 5 | 191 | 3 | CID005356151 | |
| Drug | 4H-1,4-benzothiazin-3-one | 5.74e-06 | 5 | 191 | 3 | CID000021396 | |
| Drug | Y-acid | 5.74e-06 | 5 | 191 | 3 | CID000007022 | |
| Drug | C16AA | 5.74e-06 | 5 | 191 | 3 | CID000488017 | |
| Drug | auranthine | 5.74e-06 | 5 | 191 | 3 | CID000130919 | |
| Drug | Ant-ATP | 5.74e-06 | 5 | 191 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 5.74e-06 | 5 | 191 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 5.74e-06 | 5 | 191 | 3 | CID005748474 | |
| Drug | Ac-dvda | 5.74e-06 | 5 | 191 | 3 | CID000146768 | |
| Drug | Gonadotropins | 5.74e-06 | 5 | 191 | 3 | ctd:D006062 | |
| Drug | VUF 4576 | 5.74e-06 | 5 | 191 | 3 | CID000132784 | |
| Drug | AC1L9KB4 | 6.09e-06 | 15 | 191 | 4 | CID000446969 | |
| Drug | acrylodan | 7.38e-06 | 56 | 191 | 6 | CID000104901 | |
| Drug | cilostamide | 7.99e-06 | 120 | 191 | 8 | CID000002753 | |
| Drug | ICI D7114 | 1.05e-05 | 17 | 191 | 4 | CID000121877 | |
| Drug | AC1NSV6X | 1.14e-05 | 6 | 191 | 3 | CID005317173 | |
| Drug | 1,2-dichloro-4-nitrobenzene | 1.14e-05 | 6 | 191 | 3 | ctd:C028328 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 1.14e-05 | 6 | 191 | 3 | CID000004307 | |
| Drug | 2,5-diketocamphane | 1.14e-05 | 6 | 191 | 3 | CID000020218 | |
| Drug | benziodarone | 1.14e-05 | 6 | 191 | 3 | CID000006237 | |
| Drug | AC1LCMSV | 1.14e-05 | 6 | 191 | 3 | CID000633347 | |
| Drug | CI-922 | 1.14e-05 | 6 | 191 | 3 | CID000146938 | |
| Drug | caged PE | 1.14e-05 | 6 | 191 | 3 | CID000192405 | |
| Drug | AC1L19BP | 1.34e-05 | 18 | 191 | 4 | CID000000477 | |
| Drug | NAADP | 1.80e-05 | 39 | 191 | 5 | CID000123952 | |
| Drug | 1-(4-pyridyl)ethanol | 1.98e-05 | 7 | 191 | 3 | CID000090919 | |
| Drug | AC1L52O2 | 1.98e-05 | 7 | 191 | 3 | CID000196983 | |
| Drug | chloronitromethane | 1.98e-05 | 7 | 191 | 3 | CID000074529 | |
| Drug | trifluoperazine sulfoxide | 1.98e-05 | 7 | 191 | 3 | CID000159622 | |
| Drug | DyCl3 | 1.98e-05 | 7 | 191 | 3 | CID000066207 | |
| Drug | DAPpNP | 1.98e-05 | 7 | 191 | 3 | CID005492375 | |
| Drug | T 7188 | 1.98e-05 | 7 | 191 | 3 | CID000003311 | |
| Drug | MS-857 | 1.98e-05 | 7 | 191 | 3 | CID000129517 | |
| Drug | SQ 65442 | 1.98e-05 | 7 | 191 | 3 | CID000128039 | |
| Drug | AC1L3PE4 | 1.98e-05 | 7 | 191 | 3 | CID000093048 | |
| Drug | O-4-(ethoxybutyl)berbamine | 1.98e-05 | 7 | 191 | 3 | CID000188375 | |
| Drug | TZC-5665 | 1.98e-05 | 7 | 191 | 3 | CID006449836 | |
| Drug | KHL-8430 | 1.98e-05 | 7 | 191 | 3 | CID000195711 | |
| Drug | CPU57 | 1.98e-05 | 7 | 191 | 3 | CID000195730 | |
| Drug | Drnflrfamide | 1.98e-05 | 7 | 191 | 3 | CID000132879 | |
| Drug | 4-hydroxyphenylglycol | 1.98e-05 | 7 | 191 | 3 | CID003081980 | |
| Drug | indo-1 | 2.03e-05 | 99 | 191 | 7 | CID000105060 | |
| Drug | DEPMPO | 2.09e-05 | 20 | 191 | 4 | CID000119606 | |
| Drug | haloperidol | PDE4B AKR1D1 CHRM5 AGT AKR1B10 VPS13A SDS ADCY4 CALM1 CALM2 CALM3 IFT57 AKR1B15 | 3.04e-05 | 394 | 191 | 13 | CID000003559 |
| Drug | acetaldehyde | SPTA1 CFTR LONP1 AKR1B10 SDS DYNC1H1 CALM1 CALM2 CALM3 SPAG9 CPT1A ALDH4A1 | 3.04e-05 | 338 | 191 | 12 | CID000000177 |
| Drug | N Nd | 3.12e-05 | 22 | 191 | 4 | CID000119325 | |
| Drug | proxyl nitroxide | 3.16e-05 | 8 | 191 | 3 | CID000076702 | |
| Drug | niludipine | 3.16e-05 | 8 | 191 | 3 | CID000089767 | |
| Drug | Ro 22-4839 | 3.16e-05 | 8 | 191 | 3 | CID000065839 | |
| Drug | HT-74 | 3.16e-05 | 8 | 191 | 3 | CID000126681 | |
| Drug | kahweol palmitate | 3.16e-05 | 8 | 191 | 3 | ctd:C033997 | |
| Drug | 2,6-ANS | 3.16e-05 | 8 | 191 | 3 | CID002762570 | |
| Drug | AC1MJ4D0 | 3.16e-05 | 8 | 191 | 3 | CID003085362 | |
| Drug | 3,7,8-trihydroxy-CPZ | 3.16e-05 | 8 | 191 | 3 | CID000467415 | |
| Drug | KS-504a | 3.16e-05 | 8 | 191 | 3 | CID000129577 | |
| Drug | NSP-805 | 3.16e-05 | 8 | 191 | 3 | CID000130349 | |
| Drug | N(omega)-hydroxy-L-arginine | 3.18e-05 | 72 | 191 | 6 | CID000123895 | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.26e-05 | 189 | 191 | 9 | 4304_DN | |
| Drug | cobalt(II) chloride | 3.33e-05 | 146 | 191 | 8 | CID000024288 | |
| Drug | MAPS | 3.54e-05 | 191 | 191 | 9 | CID000066161 | |
| Drug | Pipemidic acid [51940-44-4]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.68e-05 | 192 | 191 | 9 | 6752_DN | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 3.12e-07 | 10 | 186 | 4 | C1631597 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 2.05e-05 | 26 | 186 | 4 | DOID:9351 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ABCA3 ZNF155 CFTR SH3TC1 PTPRN2 AKR1B10 VPS13A FLNC DNAH3 ANK2 LMNB2 IDH1 ABCE1 SETBP1 B4GALNT2 | 4.23e-05 | 702 | 186 | 15 | C0009402 |
| Disease | Ciliopathies | 7.20e-05 | 110 | 186 | 6 | C4277690 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 1.18e-04 | 3 | 186 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Romano-Ward Syndrome | 1.30e-04 | 16 | 186 | 3 | C0035828 | |
| Disease | Intellectual Disability | AHI1 CHD3 ZNF462 DYNC1H1 PUF60 ZCCHC8 CHAMP1 CERT1 SETBP1 ALDH4A1 PAX6 | 1.36e-04 | 447 | 186 | 11 | C3714756 |
| Disease | autistic disorder (implicated_via_orthology) | 2.35e-04 | 4 | 186 | 2 | DOID:12849 (implicated_via_orthology) | |
| Disease | Familial aplasia of the vermis | 2.60e-04 | 20 | 186 | 3 | cv:C0431399 | |
| Disease | Bronchiectasis | 3.47e-04 | 22 | 186 | 3 | C0006267 | |
| Disease | sick sinus syndrome (is_implicated_in) | 3.90e-04 | 5 | 186 | 2 | DOID:13884 (is_implicated_in) | |
| Disease | JOUBERT SYNDROME 17 | 3.90e-04 | 5 | 186 | 2 | C3553264 | |
| Disease | coronary artery disease | INPP5D CFTR DAB1 AS3MT CNPY2 AGT PLCB2 FKBP5 ANKS1A DPP6 LMNB2 CERT1 OPHN1 FAM83B KIAA1217 B4GALNT2 PRDM16 PLCE1 | 5.82e-04 | 1194 | 186 | 18 | EFO_0001645 |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 5.83e-04 | 6 | 186 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 6.35e-04 | 228 | 186 | 7 | EFO_0003948, MONDO_0004975 | |
| Disease | Phencyclidine-Related Disorders | 8.13e-04 | 7 | 186 | 2 | C0236742 | |
| Disease | Disseminated Intravascular Coagulation | 8.13e-04 | 7 | 186 | 2 | C0012739 | |
| Disease | Phencyclidine Abuse | 8.13e-04 | 7 | 186 | 2 | C0031391 | |
| Disease | Marijuana Abuse | 8.83e-04 | 30 | 186 | 3 | C0024809 | |
| Disease | birth weight | 1.02e-03 | 399 | 186 | 9 | EFO_0004344 | |
| Disease | Attached earlobe | 1.08e-03 | 8 | 186 | 2 | HP_0009907 | |
| Disease | X-17676 measurement | 1.08e-03 | 8 | 186 | 2 | EFO_0800785 | |
| Disease | smoking cessation | 1.12e-03 | 325 | 186 | 8 | EFO_0004319 | |
| Disease | symmetrical dimethylarginine measurement | 1.38e-03 | 9 | 186 | 2 | EFO_0006523 | |
| Disease | infection | 1.38e-03 | 9 | 186 | 2 | EFO_0000544 | |
| Disease | Schizophrenia | DOCK4 PDE4B AHI1 PDE4D CETN1 CHD4 CHRM5 DNMT1 HNRNPA3 RGS12 KMO GSTA1 ZNF74 PAX6 | 1.50e-03 | 883 | 186 | 14 | C0036341 |
| Disease | Primary ciliary dyskinesia | 1.51e-03 | 36 | 186 | 3 | cv:C0008780 | |
| Disease | Asthma | 1.66e-03 | 80 | 186 | 4 | C0004096 | |
| Disease | Cannabis Abuse | 1.72e-03 | 10 | 186 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 1.72e-03 | 10 | 186 | 2 | C0236735 | |
| Disease | Hashish Abuse | 1.72e-03 | 10 | 186 | 2 | C0018614 | |
| Disease | glucagon-like peptide-1 measurement | 1.72e-03 | 10 | 186 | 2 | EFO_0008465 | |
| Disease | Profound Mental Retardation | 1.92e-03 | 139 | 186 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.92e-03 | 139 | 186 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.92e-03 | 139 | 186 | 5 | C0917816 | |
| Disease | coagulation factor XA measurement | 2.09e-03 | 11 | 186 | 2 | EFO_0020266 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 2.36e-03 | 42 | 186 | 3 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | Thromboembolism | 2.50e-03 | 12 | 186 | 2 | C0040038 | |
| Disease | Neurobehavioral Manifestations | 2.50e-03 | 12 | 186 | 2 | C0525041 | |
| Disease | QRS complex, QRS duration | 2.88e-03 | 45 | 186 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | coagulation factor X measurement | 2.95e-03 | 13 | 186 | 2 | EFO_0020265 | |
| Disease | esophageal squamous cell carcinoma | 2.95e-03 | 13 | 186 | 2 | EFO_0005922 | |
| Disease | intermediate coronary syndrome (is_marker_for) | 2.95e-03 | 13 | 186 | 2 | DOID:8805 (is_marker_for) | |
| Disease | testosterone measurement | DOCK4 PDE4B TRIM4 AKR1D1 AS3MT FAM47E TAF4 FKBP4 DPP6 NRBF2 ANK2 NRDC CHAMP1 OPHN1 AKR1B15 RIMBP2 SOS2 | 3.02e-03 | 1275 | 186 | 17 | EFO_0004908 |
| Disease | Thrombus | 3.07e-03 | 46 | 186 | 3 | C0087086 | |
| Disease | Primary Ciliary Dyskinesia | 3.26e-03 | 47 | 186 | 3 | C4551720 | |
| Disease | gastric ulcer (implicated_via_orthology) | 3.42e-03 | 14 | 186 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 3.42e-03 | 14 | 186 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | atrial fibrillation (is_implicated_in) | 3.42e-03 | 14 | 186 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | myopathy (implicated_via_orthology) | 3.46e-03 | 48 | 186 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Thrombosis | 3.67e-03 | 49 | 186 | 3 | C0040053 | |
| Disease | 1,3,7-trimethylurate measurement | 3.93e-03 | 15 | 186 | 2 | EFO_0021172 | |
| Disease | parental longevity | 4.29e-03 | 494 | 186 | 9 | EFO_0007796 | |
| Disease | response to acetylsalicylate | 4.47e-03 | 16 | 186 | 2 | GO_1903492 | |
| Disease | Cannabis Dependence | 5.05e-03 | 17 | 186 | 2 | C0006870 | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 5.05e-03 | 17 | 186 | 2 | DOID:11984 (is_marker_for) | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 5.53e-03 | 335 | 186 | 7 | EFO_0009931 | |
| Disease | esophageal adenocarcinoma | 5.66e-03 | 18 | 186 | 2 | EFO_0000478 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 6.30e-03 | 19 | 186 | 2 | DOID:9562 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LILFEEVDVIFDEDA | 1301 | Q96QE3 | |
| FFEELAVEDKQAGEE | 41 | Q8NE71 | |
| EFIDSTEQLEEFDLE | 376 | Q8WYN0 | |
| SEEINEEDLKECFFD | 821 | P13569 | |
| TEEQIAEFKEAFSLF | 6 | P0DP25 | |
| AVDEENAFLRKEFSD | 196 | Q9NXG0 | |
| QIFDTFFAEQIEKDD | 626 | P26358 | |
| VEVFDSEEAEIFQKK | 531 | Q9NPI1 | |
| DDFLFNEETKIEVLV | 401 | Q8NHY0 | |
| FFEILDFLSVDEIKN | 446 | Q8N157 | |
| EEIEFSQLIFKEDFL | 1891 | Q86TB3 | |
| KENFQIFDFSLTEEE | 281 | P51857 | |
| EKEDIFAESFEQLCL | 241 | Q86SQ4 | |
| EEDFEEQTLTLIFLD | 5291 | Q8WXG9 | |
| DCIIVDSDNFKFVVD | 2406 | Q8IYW2 | |
| VEKAAFFVTLDETEE | 411 | P50416 | |
| QEALEEFKAFVDLTF | 1621 | Q99758 | |
| VENIQVFDFKLSDEE | 271 | O60218 | |
| IQAEIDAAAELIDFF | 156 | P30038 | |
| DDELDTGDAKFFQVI | 531 | Q8NFM4 | |
| EKAVTELIIDFDANA | 341 | Q92625 | |
| LKDEIADVFAQIDCF | 36 | Q9UIA0 | |
| NEISFKLGEEFEEIT | 61 | A6NFH5 | |
| VENFKTSEIQELFDI | 486 | Q6Q4G3 | |
| TEEQKQEIREAFDLF | 26 | P41208 | |
| FSDKEVAELEEIFRV | 76 | P29016 | |
| LEALVSKAEEEFFDI | 541 | Q9GZS0 | |
| SKAEEEFFDIIFAEL | 546 | Q9GZS0 | |
| TEEQIAEFKEAFSLF | 6 | P0DP24 | |
| VVDDIVSKLVFDFVE | 326 | Q9UBU7 | |
| KALLAQEQVSFFEEE | 131 | O14578 | |
| DFTELDVAAEKIDRF | 231 | P01019 | |
| IFVDFSNEEEVKQAL | 336 | Q9Y4C8 | |
| TDEEITFVFQEKEDL | 11 | O95825 | |
| ERDEFVVKIEDIETF | 1356 | Q2KHR3 | |
| TTEINFKVGEEFEEQ | 61 | P29373 | |
| AGVEFEEKFIKSAED | 26 | P08263 | |
| VEFENIDSAKECVTF | 116 | Q8WVV9 | |
| IAKDEIGEFSDNIEF | 276 | P57740 | |
| LTDDEINIAESFKEF | 76 | O60890 | |
| SFKEFAELLNEVENE | 86 | O60890 | |
| TKEQFEFALTAVAEE | 991 | Q92932 | |
| ENKAFDRNTESLFEE | 371 | O60271 | |
| EFFEEISDEASKLVD | 3476 | Q01484 | |
| LINEEEFFDAVEAAL | 316 | Q9Y5P4 | |
| SFTQEQIEALEKEFE | 216 | P26367 | |
| EFESAKGDFEKVLEV | 366 | Q13451 | |
| KDQFEFALTAVAEEV | 956 | Q16849 | |
| VAADDGEFEKFLEEL | 51 | Q7Z418 | |
| EFEQIFSDIDEKIEQ | 26 | Q8IV33 | |
| AKVQEDLEAEFQSLF | 41 | Q9BTV5 | |
| QEELDFRKSVFEEEV | 216 | Q03252 | |
| GLKDSFEAENEVFLV | 1201 | A6NM62 | |
| FFEEIKEEEEDGVNL | 781 | Q9NYF5 | |
| FGIFSEEDKDIIQAD | 146 | Q9BVA6 | |
| SEDERFKEFTSQQEE | 476 | Q9UPZ3 | |
| SEEQEFAEGFVKALE | 131 | P17535 | |
| VNSEFIVEVKEFDIE | 21 | Q86SJ6 | |
| IETVKEVEAFTFADH | 3421 | Q5CZC0 | |
| AGVEFEEKFIKSAED | 26 | P09210 | |
| IFTDVDIFKEIVEAS | 156 | Q5T0W9 | |
| EDQTAEFKEAFQLFD | 6 | P60660 | |
| EKFQFELTLDEEDSE | 676 | Q07343 | |
| TEKFQFELTLEEDGE | 731 | Q08499 | |
| DIDFDIIKNDNDTFT | 816 | Q14315 | |
| DSLNVEKEEAVFEAV | 186 | O60662 | |
| QKLFAVEEEFEDEDF | 6 | Q8N3J3 | |
| EDFQVTEEVKALTAE | 281 | P36776 | |
| TEGFKEIFESLNEEI | 561 | Q8N8V2 | |
| IDFTADQIEEFKEAF | 46 | P12829 | |
| DQIEEFKEAFSLFDR | 51 | P12829 | |
| IEKELDVDADFVETS | 211 | Q96F24 | |
| DVKSVDNDEFNISFI | 1616 | Q9UMZ3 | |
| EIADLEERAKSQFFE | 1396 | O94913 | |
| EIIQVAFKLFDVDED | 431 | Q7L5N7 | |
| EEICDFEEAKEIFQN | 61 | P04070 | |
| FEEAKEIFQNVDDTL | 66 | P04070 | |
| DKVAEAIIDAIEDFV | 1341 | Q460N5 | |
| SNKREEEEEEFNFEV | 971 | Q5T0Z8 | |
| AGVEFDEEFLETKEQ | 26 | O15217 | |
| DASLVFKVAETANEE | 326 | P61221 | |
| ELAFFANALEEVSIE | 351 | O75874 | |
| DLNDFVKTVLVDEDA | 1256 | Q4G0P3 | |
| DDAELTLNKVDEEFV | 181 | Q9NWB7 | |
| DELNVKSEEQVFEAA | 191 | O94889 | |
| FEEFEKLLTSNDVVD | 241 | O15229 | |
| SEFFENALEFAIKID | 131 | Q6ZP82 | |
| NALEFAIKIDQAEDF | 136 | Q6ZP82 | |
| EELEVIFSLFDSKEN | 216 | Q8N1I0 | |
| EFVISDRKELEEDFI | 111 | Q14019 | |
| FDEIFEATKAVTQLE | 266 | O75553 | |
| FIDIDENLLEVEAFT | 1886 | Q9H799 | |
| FIVDDFESFEKIEDN | 2481 | Q99715 | |
| FESFEKIEDNLITFV | 2486 | Q99715 | |
| FAEFELINKEEELLE | 836 | Q8TD57 | |
| FADNQIKDESFVEDI | 2491 | Q8TD57 | |
| KELENFDPSFFEEIE | 2411 | O15078 | |
| NVLQFTEEKEAFISE | 681 | Q96JM3 | |
| NLEGFLEEFADISKE | 936 | Q12873 | |
| DELIEFFSREADNVK | 146 | Q9Y2B0 | |
| FDLTKEIFEEIFAED | 2976 | Q5VT06 | |
| NFTFKEGEIVEVDEE | 291 | Q9HBK9 | |
| LKETFSLAEFCEEEE | 286 | Q9NRY5 | |
| LAETVFNFQEKVDDL | 836 | Q14204 | |
| ADLIFTVDFEIATKE | 4616 | Q14204 | |
| DASKSVDEVFDEVVQ | 176 | P30085 | |
| VDEVFDEVVQIFDKE | 181 | P30085 | |
| EQEVFSESKSFVEDL | 811 | Q9ULL0 | |
| TEEQIAEFKEAFSLF | 6 | P0DP23 | |
| NDLQEEEKASVFVEI | 146 | A0A1B0GUA9 | |
| KDEEEETVFREVVSF | 51 | Q8NFI3 | |
| EVELFEFKGEDLTEE | 131 | Q02790 | |
| VTVEDLFSEDFKIHD | 131 | P42658 | |
| KFDVDVDLFAIQCLD | 401 | Q02742 | |
| EAREVFEDSDKTNEF | 66 | P00742 | |
| NLEGFLEEFADIAKE | 926 | Q14839 | |
| FEAEEQDLFKDIQSL | 271 | Q9H4M9 | |
| FVEFELAEDAAAAID | 51 | Q9UNP9 | |
| EDEFKISDGSQDEFV | 1106 | Q96T23 | |
| ISDQEAVAAIEKFVD | 246 | P20132 | |
| FIFTDNEIKDESFLE | 3011 | Q8TE73 | |
| TEVEVKSTEEAFEVF | 266 | Q02241 | |
| EIFCEEIAKASVQDF | 396 | Q96E29 | |
| EFLAQFQSLDETKEE | 496 | Q9UBD5 | |
| SAFEQDDFEEAKEIL | 201 | Q8IWL3 | |
| TGEEEEEFFELQIVK | 1201 | Q9NQT8 | |
| DLLDEVFFNSEVDEK | 6 | O00268 | |
| VFFNSEVDEKVVSDL | 11 | O00268 | |
| SDIDEEFILKQFDID | 226 | Q6ZV65 | |
| VIFLNEEEFDIVKAA | 421 | O15034 | |
| KEFDFLVTSEEGDNE | 286 | O43815 | |
| VVKDSEENIVFEDNL | 576 | Q07890 | |
| EEDAEIIVKIFVEFS | 506 | Q9UHX1 | |
| VIDEIDFLEAFKNIQ | 431 | Q9BVQ7 | |
| FFVEEEEHFLQEAEK | 181 | Q5TA31 | |
| KEVILSSEEESFFVQ | 2126 | Q9P212 | |
| EDFIKLINSNSDVEF | 181 | Q9H3E2 | |
| QCSFEEAREIFKDAE | 81 | P08709 | |
| EFILNEHEDTEFLKD | 386 | Q8NE18 | |
| AAEEAFEVKDVLNST | 1201 | Q9HAZ2 | |
| EQKVFLHFEEEEITF | 626 | Q92835 | |
| HDFKTEDQEVITTDF | 1331 | Q5T5P2 | |
| ELESAIFLNEEEKSF | 371 | Q8TE82 | |
| NFDNFVADKDTVLLE | 71 | P13667 | |
| VLTKENFDEVVNDAD | 181 | P13667 | |
| DSQADFFENEAIKEL | 886 | Q13017 | |
| SEVQEFTAEFLEKVL | 96 | Q8NEM2 | |
| DEEFLPFKENTFDLV | 141 | Q5TEU4 | |
| LEFQESFKHIDSEFE | 96 | Q86XK3 | |
| DKEDFSSFQLLVEVA | 191 | Q9GZN2 | |
| DFVEAVKEEAAAVAA | 416 | Q969K4 | |
| EFSAEETEETFVKAE | 336 | P08912 | |
| VENIQVFDFKLSDEE | 271 | C9JRZ8 | |
| LEEQKLQEETITFFD | 5721 | Q8IVF2 | |
| TEDQKQEVREAFDLF | 26 | Q12798 | |
| NVEDFDVESKFERTV | 76 | Q96KA5 | |
| FKEIFEDVIDAANCS | 366 | Q8TCG1 | |
| DFDIEEFAKDVGAQI | 281 | Q96KP4 | |
| DFVFDDSEAIVNNKD | 41 | Q5T4D3 | |
| DVNDAIVKLFNDFDV | 301 | A0JNW5 | |
| DDAIKEADLVFISVN | 76 | O60701 | |
| LAQVIFDKNDSDFEA | 41 | Q5T6F2 | |
| EIEEFVSNLVKRFEE | 111 | Q6NZY4 | |
| KVTFEDVAIDFTQEE | 6 | Q6ZN79 | |
| EAVTFKDVAVVFTEE | 6 | Q9UK11 | |
| TDVQDVVFKLAFFEL | 2816 | Q96RL7 | |
| KINLDEAEEFFELIS | 1181 | O14924 | |
| EAEEFFELISKAQSN | 1186 | O14924 | |
| EFATLQDEAEKVDAA | 456 | Q5VZE5 | |
| SLEDVDIFEINEAFA | 311 | Q9BWD1 | |
| KFVESDADEELLFNI | 66 | Q9GZP4 | |
| FLEANKIEFEEVDIT | 26 | Q9UJC5 | |
| QIKFFEEVLLFEDEL | 146 | O75663 | |
| FIIIEELENFEKDSQ | 1416 | Q9BX26 | |
| SFSVFAEDDVKVVEK | 596 | O95155 | |
| FDDDIVEKIDAQAIE | 331 | O75317 | |
| SFEEKIENLTEEAFN | 1001 | O43847 | |
| RSKQEFQFFDEEEET | 626 | Q9GZR1 | |
| QDIFEDDIFATEAIK | 1211 | Q9Y4E1 | |
| FVTFDDHDTVDKIVV | 171 | P51991 | |
| FEEAFTAQEEKIITV | 521 | P02549 | |
| KVTFEDVAIDFTQEE | 6 | A8MWA4 | |
| NEISEKSEIFDDQFS | 71 | A0A1B0GX68 | |
| KLTFEDVAIDFTQEE | 6 | A8MUZ8 | |
| DIFFKEAIEAIAESA | 381 | Q00722 | |
| DNFLDEIIAFQADKS | 71 | Q92797 | |
| FKDVAVVFTEEELEL | 36 | Q9UJW7 | |
| EAVTFKDVAVVFTEE | 6 | Q9UK10 | |
| EAVTFKDVAVAFTEE | 6 | Q9NYT6 | |
| KVTFEDVAIDFTQEE | 6 | P0CI00 | |
| KVTFEDVAIDFTQEE | 6 | P0CH99 | |
| ITFEQFQEALEELAK | 111 | O94811 | |
| EAVTFKDVAVVFTEE | 6 | Q12901 | |
| EVEFSSIKDEFAIAE | 56 | Q96JM2 | |
| ESVSFKDVAVDFTQE | 41 | Q16587 | |
| FELIFDSLQDDEEVE | 121 | Q13445 | |
| KVQEDAEDVLFSLGF | 156 | A2RU30 | |
| DKETRDFLFVNTEDE | 561 | Q70CQ4 | |
| TEFSKLHNFLVEEED | 201 | Q9C037 | |
| LEEQEFSIKEANFTE | 86 | Q9Y6X0 | |
| EAVTFKDVAVAFTEE | 6 | Q14590 | |
| SVTFQDVAVDFTEKE | 56 | Q96PQ6 | |
| EAVTFKDVAVVFSEE | 6 | Q02386 | |
| FDADVKEEFVEDAAA | 556 | Q9H3U1 | |
| IDEIDELFKEANAIE | 86 | Q9BXU0 | |
| EAVTFKDVIVDFTQE | 26 | Q99676 | |
| EAVTFKDVAVIFTEE | 6 | Q9UK12 | |
| EAVTFKDVAVVFTEE | 6 | Q2VY69 | |
| KLTDNIQDEFFIAVE | 4256 | Q5THJ4 | |
| FTFNKEDTEIEGLEV | 496 | Q86W25 | |
| QKEFSVGIIDDDIFE | 461 | P57103 |